期刊文献+

基于MRM-MS技术的蛋白质生物标志物研究的前景 被引量:2

Strategies for novel protein biomarker identification through multiple reaction monitoring mass spectrometry
原文传递
导出
摘要 随着蛋白质组学技术的兴起,疾病生物标志物的研究发展迅速,但筛选出的海量候选标志物却极少进入临床应用。近几年,基于MRM—MS技术的方法和策略凭借其低成本、耗时短、高灵敏度、高准确性等优势引起了国内外检验医学界的广泛关注。基于MRM—MS的技术,特别是SISCAPA技术,可能在不远的将来将逐步发展成为蛋白质生物标志物研究的快车道。本文分析了当前生物标志物研究领域的瓶颈,系统阐述了MRM—MS技术的原理和特点,以及近年来该技术在蛋白质生物标志物研究领域的主要应用现状,并展望其发展前景。 With the development of proteomic technologies, large numbers of putative biomarkers have been screened out but few of them are put into the clinical application. Recently, MRM-MS based approaches and strategies have aroused extensive concern in domestic and overseas clinical laboratory community because of their cost-efficiency, time-saving, high analytical sensitivity and accuracy. MRM-MS hased approaches, especially SISCAPA, may gradually become a key technology for the protein biomarker research in the near future. In this review, the " bottleneck" existing in the field of protein biomarkers research, and features as well as applications of MRM-MS are discussed and the future trend of research is prospected.
作者 韩冰 王立顺
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2011年第6期484-488,共5页 Chinese Journal of Laboratory Medicine
基金 国家自然科学基金资助项目(81071668) 国家高技术研究发展计划(863计划)资助课题(2006AA022105)
关键词 生物学标记 蛋白质组 肽类 质谱分析法 Biological markers Proteome Peptides Mass spectrometry
  • 相关文献

参考文献26

  • 1Trusheim MR,Berndt ER,Douglas FL.Stratified medicine:strategic and economic implications of combining drugs and clinical biomarkers.Nat Rev Drug Discov,2007,6:287-293.
  • 2Etzioni R,Urban N,Ramsey S,et al.The case for early detection.Nat Rev Cancer,2003,3:243-252.
  • 3Rifai N,Gillette MA,Carr SA.Protein biomarker discovery and validation:the long and uncertain path to clinical utility.Nat Biotechnol,2006,24:971-983.
  • 4Makawita S,Diamandis EP.The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches:current strategies for candidate verification.Clin Chem,2010,56:212-222.
  • 5Anderson NL,Anderson NG,Haines LR,et al.Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA).J Proteome Res,2004,3:235-244.
  • 6Barnidge DR,Goodmanson MK,Klee GG,et al.Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry.J Proteome Res,2004,3:644-652.
  • 7Kuhn E,Wu J,Karl J,et al.Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards.Proteomics,2004,4:1175-1186.
  • 8Hortin GL.A new era in protein quantification in clinical laboratories:application of liquid chromatography-tandem mass spectrometry.Clini Chem,2007,53:543-544.
  • 9McIntosh M,Fitzgibbon M.Biomarker validation by targeted mass spectrometry.Nat Biotechnol,2009,27:622-623.
  • 10Barr JR,Maggio VL,Patterson DG Jr,et al.Isotope dilution--mass spectrometric quantification of specific proteins:model application with apolipoprotein A-I.Clini Chem,1996,42:1676-1682.

同被引文献78

  • 1Aebersold R, Mann M. Mass spectrometry-based proteomics.Nature, 2003,422(6928): 198-207.
  • 2Kuster B, Schirle M, Mallick P, et al. Scoring proteomes withproteotypic peptide probes. Nat Rev Mol Cell Biol, 2005, 6(7):577-583.
  • 3Domon B, Aebersold R. Options and considerations when selectinga quantitative proteomics strategy. Nat Biotechnol, 2010,28 (7):710-721.
  • 4Baty J D, Robinson P R. Single and multiple ion recordingtechniques for the analysis of diphenylhydantoin and its majormetabolite in plasma. Biomed Mass Spectrom, 1977,4(1): 36-41.
  • 5Bronstrup M. Absolute quantification strategies in proteomics basedon mass spectrometry. Expert Rev Proteomics, 2004,1(4): 503-512.
  • 6Lange V,Picotti P, Domon B, et al. Selected reaction monitoringfor quantitative proteomics: a tutorial. Mol Syst Biol, 2008,4: 222.
  • 7Calvo E,Camafeita E,Femandez-Gutierrez B, et al. Applyingselected reaction monitoring to targeted proteomics. Expert RevProteomics, 2011,8(2): 165-173.
  • 8Mallick P, Schirle M,Chen S S, et al. Computational prediction ofproteotypic peptides for quantitative proteomics. Nat Biotechnol,2007, 25(1): 125-131.
  • 9de Graaf E, Altelaar M,van Breukelen B, et al. Improving SRMassay development: A global comparison between triplequadrupole, ion trap and higher energy CID peptide fragmentationspectra. J Proteome Res, 2011,10(9): 4334-4341.
  • 10Mead J A, Bianco L, Ottone V,et cd. MRMaid, the web-based toolfor designing multiple reaction monitoring (MRM) transitions. MolCell Proteomics, 2009,8(4): 696-705.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部